Results 231 to 240 of about 1,544,422 (378)
Abstract Genetic tumor risk syndromes (genturis) contribute substantially to the overall cancer burden and provide opportunities for early detection, prevention, and individualized treatment. Yet, many affected individuals remain undiagnosed due to restrictive testing criteria and challenges in variant interpretation.
Mayra Sauer +11 more
wiley +1 more source
Fragile X syndrome due to a missense mutation
L. K. Myrick +5 more
semanticscholar +1 more source
A missense mutation in Muc2 promotes gut microbiome and metabolome-dependent colitis-associated tumorigenesis. [PDF]
Verna G +14 more
europepmc +1 more source
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja +11 more
wiley +1 more source
A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS.
Evelyne Huynh Cong +23 more
semanticscholar +1 more source
Sideroblastic anemia: functional study of two novel missense mutations in
Manuel Méndez +5 more
openalex +1 more source
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan +3 more
wiley +1 more source
A novel MKRN3 missense mutation causing familial precocious puberty.
L. D. Vries +8 more
semanticscholar +1 more source
Supplementary Table 6 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling [PDF]
Ruyi Zhang +11 more
openalex +1 more source

